Diabetes and cardiovascular risk

David Karásek

Prakt. Lékáren. 2018; 14(3e)  

Diabetes mellitus is a major risk factor for atherosclerosis and generally, patients with diabetes have a considerably higher cardiovascular riskthan individuals without diabetes. But especially in the last time, this risk seems to be rather heterogeneous. It is high, very high or even extremefor most diabetics. However, it can match the risk in general population for smaller part of diabetic patients. This review deals with mainfactors for cardiovascular risk in diabetics and possibilities of its improvement.

Intranasal application of drugs at children

Eva Kašáková, Viktor Kašák

Prakt. Lékáren. 2018; 14(3e)  

Intranasal application of drugs represents primarily a topical treatment. Education in correct application technique is very important, becausecorrect application technique increases compliance of patients to treatment.

Hormonal contraception used by adolescents and the risk of tromboembolic disease – topical look

Miroslav Havlín

Prakt. Lékáren. 2018; 14(3e)  

This article summarize the basic options for contraceptive security of adolescent girls, including benefits a risks of hormonal contraception.It also draws attention to the broader social context of unwanted pregnancies in this age group. Points out the main aspects of the care foryoung people and the most common health problems influencing use of contraceptives.The second part deals in detail with pathogenesis ofthromboembolic disease and analyzes the major risk factors for its occurrence. It discusses the relationship between thrombophilic mutations to hormonal treatment and presents prescribing recommendations for risk groups of women. This text...

Hormonal contraception used by adolescents and the risk of tromboembolic disease – topical look – part 2

Miroslav Havlín

Prakt. Lékáren. 2018; 14(3e)  

This article deals in detail with pathogenesis of thromboembolic disease and analyzes the major risk factors for its occurrence. It discussesthe relationship between thrombophilic mutations to hormonal treatment and presents prescribing recommendations for risk groups ofwomen. This text mainly underlines that the emergence of thromboembolism is multifactorial.

Kontaminace cytotoxickými léčivy a jejich dekontaminace v lékárnách a nemocnicích ČR

Lenka Doležalová

Prakt. Lékáren. 2018; 14(3e): e38-e40  

E-verze 3/18

Prakt. Lékáren. 2018; 14(3e)